Timing of vaginal misoprostol administration for cervical priming among women undergoing vaginoscopic hysteroscopy: a randomized controlled trial
Obstetrics & Gynecology Science · 15.11.2026 · 69 (6) · 476-484
DOI: 10.5468/ogs.26197 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.11.2026. Verfasst von Smitha Priyadarshini Thippeswamy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynaecology, Jawaharlal Institute of Post-graduate Medical Education & Research, Puducherry, India. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To compare the ease of cervical entry after administration of vaginal misoprostol at two different intervals before vaginoscopic hysteroscopy.
Methods
In this randomized, double-blinded study, 140 women undergoing vaginoscopic hysteroscopy were allocated into two groups: 1) short-interval: placebo tablet administered vaginally 12 hours before the procedure, followed by 200 mcg vaginal misoprostol 3 hours before and 2) long-interval: 200 mcg vaginal misoprostol 12 hours before the procedure and a placebo tablet 3 hours before. The primary outcome was the ease of cervical entry, evaluated using a 5-point Likert scale, and the secondary outcomes included 1) time interval to cervical entry and completion of the procedure, 2) pain assessment using a visual analog scale (VAS), and 3) any adverse effects associated with the drug or procedure.
Results
All except two patients with cervical stenosis underwent vaginoscopic hysteroscopy. The proportion of patients who reported “easy” or “very-easy” cervical entry was similar in both groups (64.3% [95% confidence interval [CI], 53.1-75.5], vs. 72.9% [95% CI, 62.4-83.3]; P=0.275). Pain perception was lower in the long-interval group than in the short-interval group (P=0.024). However, the temporal change in the pain score was not significantly different between the groups. The side effects of misoprostol were mild, self-limiting, and similar in both groups.
Conclusion
Vaginal misoprostol administration 12 hours before vaginoscopic hysteroscopy was associated with a similar ease of entry but a lower perception of pain using the VAS than misoprostol administration 3 hours before the procedure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics & Gynaecology, Jawaharlal Institute of Post-graduate Medical Education & Research, Puducherry, India.
- Department of Obstetrics & Gynaecology, Jawaharlal Institute of Post-graduate Medical Education & Research, Puducherry, India. dilipkm2@gmail.com.
Zitieren
APA
Thippeswamy, S. P., Maurya, D. K., Puttaswamy, R. G., & Keepanasseril, A. (2026). Timing of vaginal misoprostol administration for cervical priming among women undergoing vaginoscopic hysteroscopy: a randomized controlled trial. Obstetrics & Gynecology Science, 69(6), 476-484. https://doi.org/10.5468/ogs.26197
Vancouver
Thippeswamy SP, Maurya DK, Puttaswamy RG, Keepanasseril A. Timing of vaginal misoprostol administration for cervical priming among women undergoing vaginoscopic hysteroscopy: a randomized controlled trial. Obstetrics & Gynecology Science. 2026;69(6):476-484. doi:10.5468/ogs.26197
BibTeX
@article{Thippeswamy2026,
author = {Thippeswamy, Smitha Priyadarshini and Maurya, Dilip Kumar and Puttaswamy, Raju Govindegowdanadoddi and Keepanasseril, Anish},
title = {Timing of vaginal misoprostol administration for cervical priming among women undergoing vaginoscopic hysteroscopy: a randomized controlled trial},
journal = {Obstetrics & Gynecology Science},
year = {2026},
volume = {69},
number = {6},
pages = {476--484},
doi = {10.5468/ogs.26197}
}
EUVIMED